Series Embark Kyoto University Innovation Capital, Co. Ltd. Kyoto-iCAP MaRI Co., Ltd. Melody International Ltd. Luxonus Inc. Kola-gen Pharma Inc. CleanHearing, Inc. Stem Cell & Device Laboratory Inc. AFI Corporation Restore Vision Inc. Link Therapeutics Inc. Cellshoot Therapeutics, Inc. Eurus Therapeutics Co., Ltd. Orizuru Therapeutics Inc. BTB Therapeutics Co.,Ltd. Perseus Corporation Toregem BioPharma Co., Ltd. Rege Nephro Co., Ltd. FIMECS, Inc. Myoridge Co., Ltd. AlphaNavi Pharma Inc. CUORiPS Inc. aceRNA Technologies Co., Ltd. Chordia Therapeutics, Inc. Oligogen KinoPharma, Inc. Kyoto Drug Discovery & Development Co., Ltd. TSK Corporation Mitate Zepto Technica, Inc. OPTMASS Co., Ltd. Symbiobe Inc. Saki Corporation DPS Inc. U-MAP Co., Ltd. Kyoto Fusioneering Ltd. Kyulux, Inc. Enecoat Corporation Space Power Technologies, Inc. CONNEXX SYSTEMS Co., Ltd. FLOSFIA Inc. tiem factory Inc. KyotoTextLab LegalOn Technologies, Inc. Questetra Inc. mitsucari Inc. Lang-8 Inc. HOLO BIO CO., LTD. Sunlit Seedlings Ltd. Ocean Eyes Co., Ltd. Algal Bio Co., Ltd. Entrepreneur in Residence Ko Kusumi Nobuhiro Yagi Hiroyuki Ueno Osami Kono Kenichi Yotsumoto Masayoshi Ohbayashi Masahiro Shinohara Satoru Morita Takane Hosoyama Atsushi Mazawa Shogo Otani Koji Yokoo Tsuyoshi Tsujimura Ryuhi Kanno Teruo Susumu Nobuhiro Tsushi Minoru Furukawa Yuji Takeda Yasumichi Hitoshi Ryosuke Gonotsubo Yusuke Tanaka Hidekazu Kasahara Kunihiro Musashi Hanako Ikeda Atsushi Wakamiya Naoya Kato Taka Nagao Satoshi Konishi Kunihiko Ono Kenji Osafune Toshihiro Ishikiriyama Hongzhi Bai Yoshihiro Oyamada Hirotsugu Hayashi Kensuke Kato Hisashi Tsukamoto Yuko Ogata Keiji Ninomiya Takanori Omote Daisuke Morishita Kentaro Kume Honoka Kiso Katsu Takahashi Sadakazu Aiso Takayuki Yagi Amane Kimura Tsuyoshi Takeshita Yusuke Tominari Kanae Gamo Kenji Nonaka Shinji Ogawa Nozomu Tsunoda Osumi Kono CUORiPS Inc. General Partner Maturity JPY 35,000,000 JPY 16,001 million JPY 18,140 million Investment business (as part of “support program for utilizing specified research results”
approved by MEXT and METI based on the Industrial Competitiveness Enhancement Act.) Business By December 2030 (+5 years’ extension) By December 2032 (+5 years’ extension) Innovation Kyoto 2016 Investment Limited Liability Partnership Innovation Kyoto 2021 Investment Limited Liability Partnership 2nd Fund 1st Fund Regional Fish Institute, Ltd. Time Therapeutics, Inc. HiLung Inc. OOYOO Ltd. QunaSys Inc. Nature Gifts Co., Ltd. collaborative research SAKA NO TOCHU Co., Ltd. Sota Ishikawa Hirokazu Toju Yoshiko Abe Masayoshi Aosasa Masahiro Shiokawa Department of Gastroenterology and Hepatology, Gtaduate School of Medicine, Kyoto University Kaoruko Morino Misao Morita Son Eun-Cheol Shoji Nakamura Institute for Chemical Research, Kyoto University International Research Center for Elements Science, Institute for Chemical Research, Kyoto University Mizuho Takita GRA&GREEN Inc. Masaki Niwa Kazuhiro Nakashoji RegCell Co.,Ltd large gauge steel Shaobun Morinaka Masago Umeda Toshihide Kobayashi Rhinoflux Inc. Ryuichi Roda Graduate School of Engineering, Kyoto University Kenji Nishitani Toru Ujihara Takahiro Maeda Department of Materials Science and Engineering, Graduate School of Engineering, Nagoya University 堅田侑作 宮﨑輝 京都大学理学部生物物理学教室 神取秀樹 慶應義塾大学医学部大学院医学研究科 慶應義塾大学医学部眼科学教室 Raymond Woo
Contact UsCONTACT
Please feel free to contact us if you have any questions or concerns.